On October 16, 2019, we received the feedback of change notice from Hanhui Pharmaceutical Co., Ltd. (see Attachment C: feedback form of change notice from Hanhui Pharmaceutical Co., Ltd.) again. After further confirming the details of change, in order to comprehensively inspect the product quality, Haizheng is required to take 3 batches of 5-10 mg of rosuvastatin calcium tablets for accelerated and long-term stability study.<br>
正在翻译中..